# Arcadia Biosciences, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Arcadia Biosciences, Inc.). ## Overview Arcadia Biosciences, Inc. is a U.S.-based commercial-stage company that has shifted from agricultural trait development toward consumer products and selective monetization of intellectual property. Its current operating business centers on Zola coconut water products, while legacy wheat trait assets and the GoodWheat brand have been sold or exited. The company also has a history of licensing and royalty activity tied to wheat-based technologies, but it no longer expects future license or royalty income from its wheat intellectual property. Recent disclosures show a business in transition, with product sales, asset sales, and patent monetization playing a larger role than ongoing agricultural R&D commercialization. ## Products & services • Zola coconut water products • GLA oil products • Product sales to distributors and retailers • Sale of intangible assets and patent portfolios • Legacy wheat trait licensing and royalty rights (largely exited) - **Beverage products** (70%) — Coconut water and related hydration products sold under the Zola brand. - **Nutritional oils** (10%) — GLA oil products sold through product channels, with sales ending at the close of 2024. - **Intellectual property monetization** (15%) — Sales of patents, pending applications, and related intangible assets from legacy agricultural technologies. - **Legacy agricultural technology** (5%) — Residual wheat trait-related commercialization and licensing activity, now largely exited. - Zola coconut water products - GLA oil products - Product sales to distributors and retailers - Sale of intangible assets and patent portfolios - Legacy wheat trait licensing and royalty rights (largely exited) ## Customers Arcadia’s current customers are primarily third-party distributors and retailers that buy Zola coconut water and related beverage products for resale to end consumers. The company also sells GLA products through product channels, although that business has been winding down. Historically, Arcadia also served agricultural and food-industry counterparties through seed, grain, ingredient, and trait-licensing arrangements, but those activities have been materially reduced or exited. The customer base is therefore a mix of consumer-product channel partners today and legacy technology counterparties from its earlier agricultural business model. - **Beverage distributors and retailers** (primary) — Buy Zola coconut water for resale in grocery, convenience, and other beverage channels because the product is a branded hydration item with seasonal consumer demand. - **GLA product channel buyers** (secondary) — Purchase GLA oil products through product sales channels, although this segment has diminished as GLA oil sales ceased at the end of 2024. - **Intellectual property acquirers and licensees** (secondary) — Buy or license patent portfolios and related rights, such as the March 2025 sale of reduced gluten and oxidative stability patents and the 2024 RS durum wheat trait sale. - **Legacy agricultural commercialization partners** (emerging) — Previously bought seed, grain, food ingredients, and trait rights tied to wheat technologies, but this segment is now largely exited. - Third-party distributors that purchase Zola products for channel placement - Retailers that stock coconut water for consumer resale - Manufacturers or channel buyers of GLA products - Legacy agricultural partners that previously licensed wheat traits - Intellectual property buyers such as BIOX and Corteva in asset sales ## Geography The company is headquartered in the United States and its disclosures point to a primarily U.S.-centric operating footprint. Its current business depends on domestic consumer-product distribution for Zola and on U.S.-based counterparties for intellectual property transactions and legacy asset sales. No country-level revenue breakdown was disclosed in the provided excerpts, so the geographic mix cannot be quantified from the available material. Geography matters mainly through U.S. retail channel access, domestic logistics, and exposure to U.S. consumer demand and inventory cycles. - Headquartered in the United States - Current operations are centered on U.S. consumer-product distribution - Patent and asset sales have been executed with U.S.-based counterparties - No country-level revenue disclosure was provided in the excerpts - Geographic exposure is mainly to U.S. retail demand and logistics ## Strategy Arcadia’s strategy has shifted from agricultural trait development toward monetizing remaining assets while supporting the Zola beverage business. The company has exited GoodWheat and no longer expects future wheat-based royalty income, which suggests a deliberate reduction in legacy agricultural commercialization. It is also actively managing its portfolio through patent sales and other asset monetization, as shown by the 2025 transfer of reduced gluten and oxidative stability patents and the 2024 RS durum wheat trait sale. At the operating level, the company appears focused on maintaining product sales, managing seasonal beverage demand, and preserving liquidity while operating with a small cash base. - **Support and simplify the Zola beverage business** (short-term) — Zola is the remaining operating product line and the main source of recurring product revenue. - **Monetize legacy intellectual property** (short-term) — Asset sales provide non-recurring cash and reduce the burden of maintaining non-core technologies. - **Exit or wind down non-core agricultural activities** (medium-term) — The company has already exited GoodWheat and no longer expects wheat royalty income, indicating a strategic pivot away from the old model. - Focus on Zola coconut water as the core operating brand - Exit non-core legacy wheat businesses and royalty streams - Monetize remaining intellectual property through asset sales - Manage seasonality in beverage demand and shipment timing - Preserve liquidity through disciplined cash use and asset proceeds ## Risks Arcadia faces execution and liquidity risk because its business has been reduced to a small set of product lines and asset monetization opportunities. Beverage sales are seasonal, with higher volumes in warmer quarters, which can create meaningful quarter-to-quarter volatility in revenue and inventory needs. The company also depends on third-party distributors and retailers, so shipment timing, chargebacks, returns, and freight costs can materially affect reported results. More broadly, it remains exposed to consumer demand shifts in coconut water, the risk that remaining intangible assets cannot be monetized at attractive values, and the possibility that limited cash resources constrain operations. - **Liquidity and going-concern pressure** [high] — The company has a small cash balance and has relied on equity proceeds, product sales, and asset sales to fund operations. - **Seasonality in coconut water demand** [medium] — Sales volumes are highest in the second and third fiscal quarters, making results uneven across periods. - **Dependence on third-party distributors and retailers** [medium] — Revenue is recognized on delivery and fluctuates with shipment timing, which can delay or accelerate reported sales. - **Residual intellectual property monetization risk** [high] — The company has sold key patent portfolios and no longer expects future wheat royalty income, limiting future IP cash flows. - Seasonal coconut water demand can cause large quarterly swings in revenue - Small operating scale increases liquidity and going-concern pressure - Revenue depends on distributor and retailer shipment timing - Chargebacks, returns, and losses reduce reported product revenue - Inventory write-downs can hit margins when demand or pricing weakens - Asset monetization may not continue at the same pace as recent sales ## Accounting Revenue recognition is a key accounting judgment because product revenue is recorded when control transfers to third-party distributors and retailers, generally upon delivery, and is reported net of estimated chargebacks, returns, and losses. That means shipment timing can materially affect quarterly results, especially in a seasonal beverage business. Inventory valuation is also important because management specifically identifies net realizable value of inventory as a critical estimate, and write-downs or freight-related costs flow directly into cost of revenues. The company also records gains on the sale of intangible assets and patent portfolios, so non-operating asset monetization can create volatile one-time earnings effects that investors should separate from core product performance. - **Revenue recognition on product sales** — Quarterly revenue volatility and net sales presentation - **Inventory net realizable value** — Cost of revenues and margin volatility - **Gain on sale of intangible assets** — Non-operating income and comparability - **Seasonality of beverage sales** — Revenue, inventory, and cash flow timing - Revenue is recognized at delivery, so shipment timing affects quarterly sales - Revenue is net of chargebacks, returns, and losses - Inventory net realizable value estimates can create write-downs - Freight and product costs are a major component of cost of revenues - Patent and intangible asset sales can create one-time gains - Seasonality makes quarter-to-quarter comparisons less comparable --- *Last updated: 2026-08-11T04:46:21.231107+00:00*